Table 2.
Parameter | Value in strain (mutation)a: |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
K3486 | K3809 (N369Y) | K3811 (M312T) | K4538 (F375V) | K4670 (A161V) | K4842 (S81L) | K4898 (K242E) | K4900 (N308)b | K4902 (F375I) | K4904 (A161T) | K4908 (M391T) | K4984 (M291I) | |
Selecting conditions applied to SA-K3731 | H33342, RD | DQ | EtBr, Pentc | CHX | BAC | TPP | TPP, CHX | EtBr | Pent | DAPI | DAPI | |
Location of substitutiond | TMS 10 | Loop 8-9 | TMS 10 | TMS 4e | Loop 2-3 | TMS 7e | Loop 8-9 | TMS 10 | TMS 4 | TMS 11 | TMS 8 | |
Relative susceptibility | ||||||||||||
BAC | 1 (1) | 2 (0.5) | 2 (0.5) | 2 (0.5) | 1 (0.25) | 2 (0.13) | 2 (0.06) | 2 (0.06) | 2 (0.06) | 2 (0.06) | 2 (0.06) | 2 (0.25) |
CHX | 1 (1) | 1 (0.13) | 1 (0.5) | 1 (0.25) | 1 (0.25) | 1 (0.25) | 1 (0.25) | 1 (0.13) | 0.5 (0.13) | 1 (0.25) | 1 (0.25) | 1 (0.25) |
DAPI | 1 (1) | 4 (1) | 2 (1) | 1 (0.5) | 0.5 (0.5) | 0.5 (1) | 1 (1) | 2 (0.5) | 4 (1) | 1 (1) | 2 (1) | 2 (1) |
DQ | 1 (1) | 2 (0.5) | 2 (0.5) | 1 (0.25) | 1 (0.25) | 1 (0.25) | 1 (0.25) | 2 (0.5) | 1 (0.25) | 1 (0.25) | 2 (0.5) | 1 (0.5) |
EtBr | 1 (1) | 2 (0.5) | 2 (0.5) | 2 (0.5) | 1 (0.5) | 2 (0.5) | 1 (0.5) | 2 (0.5) | 2 (0.5) | 2 (1) | 2 (1) | 2 (0.5) |
H33342 | 1 (1) | 8 (2) | 8 (2) | 1 (1) | 1 (1) | 8 (8) | 1 (1) | 4 (2) | 2 (1) | 2 (1) | 2 (0.5) | 4 (1) |
Norfloxacin | 1 (1) | 4 (2) | 4 (1) | 0.5 (0.5) | 0.5 (0.5) | 2 (2) | 1 (0.25) | 1 (0.5) | 1 (0.5) | 1 (0.5) | 1 (0.5) | 1 (0.5) |
Pent | 1 (1) | 4 (2) | 4 (2) | 2 (1) | 1 (0.5) | 2 (0.5) | 2 (0.5) | 2 (0.25) | 2 (0.25) | 1 (1) | 2 (0.25) | 2 (0.25) |
RD | 1(1) | 2(2) | 2(2) | 1(1) | 1(1) | 1(2) | 0.5(0.5) | 0.5(0.5) | 0.5(0.5) | 1(0.5) | 1(0.5) | 1(1) |
0 | ||||||||||||
TPP | 1(1) | 2(0.25) | 2(0.25) | 2(0.5) | 2(0.5) | 2(0.13) | 2(0.25) | 1(0.25) | 1(0.25) | 1(0.25) | 2(0.25) | 2(0.5) |
1 (1)EtBr efflux (%) ± SD | 27.2 ± 4.6 | 82.2 ± 0.4 | 83.1 ± 0.6 | 56.0 ± 5.8 | 40.4 ± 3.0 | 80.4 ± 2.2 | 52.9 ± 2.8 | 63.0 ± 2.0 | 66.4 ± 4.7 | 38.4 ± 5.7 | 60.3 ± 13.0 | 36.2 ± 6.6 |
% Changef | 202 | 206 | 106 | 49 | 196 | 94 | 132 | 144 | 41 | 122 | 33 | |
P value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.001 | |
IC50 for EtBr efflux (reserpine/paroxetine) | 3/1.8 | 5.2/2.7 | 3/2.6 | 4.6/3.6 | 3.8/>4.5 | 2.4/1.5 | 2.4/2.2 | 1.8/2.5 | 3.2/1.8 | 1/0.8 | 0.6/0.5 |
Susceptibility, fold reduction in MIC in the presence of 20 μg/ml reserpine (in parentheses), and IC50 data were normalized to K3486, in which wild-type mepA is expressed.
Mutation consisted of duplication of indicated residue.
Pent, pentamidine.
Predicted by SOSUI. Loop x-y, extramembrane loop connecting TMSs x and y (Fig. 1 shows details).
Alternate location predicted by TMHMM algorithm. See the text for details.
Compared to K3486.